| Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation N Arpaia, C Campbell, X Fan, S Dikiy, J Van Der Veeken, P Deroos, H Liu, ... Nature 504 (7480), 451-455, 2013 | 4277 | 2013 |
| Control of the inheritance of regulatory T cell identity by a cis element in the Foxp3 locus Y Feng, A Arvey, T Chinen, J Van Der Veeken, G Gasteiger, AY Rudensky Cell 158 (4), 749-763, 2014 | 398 | 2014 |
| Inflammation-induced repression of chromatin bound by the transcription factor Foxp3 in regulatory T cells A Arvey, J Van Der Veeken, RM Samstein, Y Feng, ... Nature immunology 15 (6), 580-587, 2014 | 227 | 2014 |
| Crosstalk between epidermal growth factor receptor-and insulin-like growth factor-1 receptor signaling: implications for cancer therapy J van der Veeken, S Oliveira, RM Schiffelers, G Storm, PMP Henegouwen, ... Current cancer drug targets 9 (6), 748-760, 2009 | 219 | 2009 |
| Memory of inflammation in regulatory T cells J van der Veeken, AJ Gonzalez, H Cho, A Arvey, S Hemmers, CS Leslie, ... Cell 166 (4), 977-990, 2016 | 180 | 2016 |
| Downregulation of EGFR by a novel multivalent nanobody-liposome platform S Oliveira, RM Schiffelers, J van der Veeken, R van der Meel, ... Journal of Controlled Release 145 (2), 165-175, 2010 | 169 | 2010 |
| A mechanism for expansion of regulatory T-cell repertoire and its role in self-tolerance Y Feng, J van der Veeken, M Shugay, EV Putintseva, HU Osmanbeyoglu, ... Nature 528 (7580), 132-136, 2015 | 168 | 2015 |
| Tumor-targeted Nanobullets: Anti-EGFR nanobody-liposomes loaded with anti-IGF-1R kinase inhibitor for cancer treatment R Van Der Meel, S Oliveira, I Altintas, R Haselberg, J Van Der Veeken, ... Journal of controlled release 159 (2), 281-289, 2012 | 111 | 2012 |
| A unified atlas of CD8 T cell dysfunctional states in cancer and infection Y Pritykin, J van der Veeken, AR Pine, Y Zhong, M Sahin, L Mazutis, ... Molecular cell 81 (11), 2477-2493. e10, 2021 | 82 | 2021 |
| The transcription factor Foxp3 shapes regulatory T cell identity by tuning the activity of trans-acting intermediaries J van der Veeken, A Glasner, Y Zhong, W Hu, ZM Wang, R Bou-Puerto, ... Immunity 53 (5), 971-984. e5, 2020 | 75 | 2020 |
| Genetic and epigenetic variation in the lineage specification of regulatory T cells A Arvey, J van der Veeken, G Plitas, SS Rich, P Concannon, ... Elife 4, e07571, 2015 | 58 | 2015 |
| Natural genetic variation reveals key features of epigenetic and transcriptional memory in virus-specific CD8 T cells J van der Veeken, Y Zhong, R Sharma, L Mazutis, P Dao, D Pe’er, ... Immunity 50 (5), 1202-1217. e7, 2019 | 51 | 2019 |
| Genetic tracing reveals transcription factor Foxp3-dependent and Foxp3-independent functionality of peripherally induced Treg cells J van der Veeken, C Campbell, Y Pritykin, M Schizas, J Verter, W Hu, ... Immunity 55 (7), 1173-1184. e7, 2022 | 48 | 2022 |
| Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity W Hu, ZM Wang, Y Feng, M Schizas, BE Hoyos, J van der Veeken, ... Nature immunology 22 (9), 1163-1174, 2021 | 47 | 2021 |
| miR-182 is largely dispensable for adaptive immunity: lack of correlation between expression and function JN Pucella, WF Yen, MV Kim, J van der Veeken, ND Socci, Y Naito, MO Li, ... The Journal of Immunology 194 (6), 2635-2642, 2015 | 33 | 2015 |
| Transcriptional control of regulatory T-cell differentiation J van der Veeken, A Arvey, A Rudensky Cold Spring Harbor symposia on quantitative biology 78, 215-222, 2013 | 25 | 2013 |
| The transcription factor FoxP3 can fold into two dimerization states with divergent implications for regulatory T cell function and immune homeostasis F Leng, W Zhang, RN Ramirez, J Leon, Y Zhong, L Hou, K Yuki, ... Immunity 55 (8), 1354-1369. e8, 2022 | 23 | 2022 |
| FXR mediates T cell-intrinsic responses to reduced feeding during infection C Campbell, F Marchildon, AJ Michaels, N Takemoto, J van der Veeken, ... Proceedings of the National Academy of Sciences 117 (52), 33446-33454, 2020 | 23 | 2020 |
| Hierarchical regulation of the resting and activated T cell epigenome by major transcription factor families Y Zhong, SK Walker, Y Pritykin, CS Leslie, AY Rudensky, ... Nature immunology 23 (1), 122-134, 2022 | 21 | 2022 |
| Storm G, van Bergen En Henegouwen PM, Roovers RC: Crosstalk between epidermal growth factor receptor-and insulin-like growth factor-1 receptor signaling: implications for … J van der Veeken, S Oliveira, RM Schiffelers Curr Cancer Drug Targets 9, 748-760, 2009 | 4 | 2009 |
alexander rudenskymskcc在 mskcc.org 的电子邮件经过验证
